|
|
| (38 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| − | *'''[[Unproven ideas]]'''
| |
| − | *'''[[Reviews on covid19 disease]]'''
| |
| | | | |
| | | | |
| | + | *'''[[Unproven ideas]]''' |
| | | | |
| | + | *'''[[Reviews on covid19 disease]]''' |
| | *'''[[Clinical guidelines and advice]]''' | | *'''[[Clinical guidelines and advice]]''' |
| − | {{tp|p=C7149288|t=2020. Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19* |pdf=|usr=}}
| + | |
| − | {{tp|p=C7162768|t=2020. Therapeutic management of patients with COVID-19: a systematic review |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Respiration mgmt]]''' | | *'''[[Respiration mgmt]]''' |
| − | {{tp|p=C7203031|t=ä. Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection? |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Diagnosis (Laboratory)]]''' | | *'''[[Diagnosis (Laboratory)]]''' |
| − | {{tp|p=C7200353|t=2020. A nanoparticle pseudo pathogen for rapid detection and diagnosis of virus infection |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| | *'''[[Diagnosis (Lung CT, Sonography)]]''' | | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| − | {{tp|p=C7203047|t=ä. Imagerie de la pneumonie COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7175452|t=ä. Deep learning system to screen coronavirus disease 2019 pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=C7166002|t=2020. CT radiomics can help screen the Coronavirus disease 2019 (COVID-19): a preliminary study |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Diagnosis (other modalities)]]''' |
| | | | |
| | | | |
| | | | |
| | | | |
| | + | *'''[[Structure of covid19]]''' |
| | | | |
| | | | |
| − |
| |
| − | *'''[[Diagnosis (other modalities)]]'''
| |
| − |
| |
| − |
| |
| − | ----
| |
| − |
| |
| − |
| |
| − | *'''[[Structure of covid19]]'''
| |
| | *'''[[Target binding and uptake]]''' | | *'''[[Target binding and uptake]]''' |
| − |
| |
| | *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| Zeile 54: |
Zeile 38: |
| | | | |
| | | | |
| − | ----
| + | |
| | *'''[[Pathobiology]]''' | | *'''[[Pathobiology]]''' |
| − | {{tp|p=C7173822|t=2020. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| | *'''[[Disease Models]]''' | | *'''[[Disease Models]]''' |
| − |
| |
| | | | |
| | | | |
| | *'''[[Similar diseases and pathomechanisms]]''' | | *'''[[Similar diseases and pathomechanisms]]''' |
| | + | |
| | | | |
| | | | |
| Zeile 73: |
Zeile 55: |
| | | | |
| | *'''[[Co-Infection]]''' | | *'''[[Co-Infection]]''' |
| − | {{tp|p=C7195315|t=2020. Co-infections: potentially lethal and unexplored in COVID-19 |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | | | |
| | *'''[[Hematology]]''' | | *'''[[Hematology]]''' |
| Zeile 86: |
Zeile 72: |
| | | | |
| | *'''[[Neurology, ophthalmology, orl]]''' | | *'''[[Neurology, ophthalmology, orl]]''' |
| − | {{tp|p=C7200324|t=ä. SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies? |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Dermatology]]''' | | *'''[[Dermatology]]''' |
| | + | |
| | | | |
| | | | |
| | *'''[[Gastroenterology, hepatology]]''' | | *'''[[Gastroenterology, hepatology]]''' |
| − | {{tp|p=C7198139|t=2020. Suspected Acute Abdomen as an Extrapulmonary Manifestation of Covid-19 Infection? |pdf=|usr=}}
| |
| − | {{tp|p=C7180357|t=ä. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19? |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Kidney, urology]]''' | | *'''[[Kidney, urology]]''' |
| | | | |
| − | | + | *'''[[The morbid survivor]]''' |
| | | | |
| | *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
| − | {{tp|p=C7197241|t=2020. ACEI inhibitors and ARBs do not increase severity of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7183935|t=ä. Status of SARS-CoV-2 infection in patients on renal replacement therapy Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN)? |pdf=|usr=}}
| |
| − | {{tp|p=C7194925|t=2020. ... COVID-19 para el paciente con insuficiencia cardiaca, trasplante cardiaco y asistencia ventricular ... |pdf=|usr=}}
| |
| − | {{tp|p=C7158793|t=2020. Neonatal COVID?19: little evidence and the need for more information? |pdf=|usr=}}
| |
| − | {{tp|p=C7169649|t=2020. EMA: continue use of ACE inhibitors, sartans during COVID-19 pandemic |pdf=|usr=}}
| |
| | | | |
| | | | |
| − |
| |
| − |
| |
| − | *'''[[The morbid survivor]]'''
| |
| | | | |
| | *'''[[Case reports]]''' | | *'''[[Case reports]]''' |
| Zeile 118: |
Zeile 93: |
| | | | |
| | | | |
| − | *'''[[Case series]]'''
| |
| − | {{tp|p=C7165248|t=2020. Auch Kinder können schwer an COVID-19 erkranken |pdf=|usr=}}
| |
| − | *'''[[Registries]]'''
| |
| − | ----
| |
| | | | |
| | | | |
| − | *'''[[Trials]]'''
| |
| | | | |
| | | | |
| − | | + | *'''[[Case series]]''' |
| − | *'''[[Candidate Compounds Covid19]]''' | + | |
| − | {{tp|p=C7203037|t=ä. (Vitamin-C; Ozone)Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19? |pdf=|usr=}}
| + | |
| − | {{tp|p=C7197234|t=2020. Safety concerns with higher dosage chloroquine in COVID-19 patients |pdf=|usr=}}
| + | |
| − | {{tp|p=C7197245|t=2020. Antimalarial use in COVID-19 patients requires close monitoring |pdf=|usr=}}
| + | |
| − | {{tp|p=C7180667|t=ä. Achilles heel of the killer virus: the highly important molecular targets for hitting SARS-CoV-2 that causes COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=C7190525|t=2020. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients |pdf=|usr=}}
| + | |
| − | {{tp|p=C7152890|t=2020. Biomimetic nanoparticles as universal influenza vaccine |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | + | *'''[[Registries]]''' |
| | | | |
| | | | |
| | + | *'''[[Trials]]''' |
| | | | |
| | + | *'''[[Candidate Compounds Covid19]]''' |
| | | | |
| | | | |
| | *'''[[Other routes of infection]]''' | | *'''[[Other routes of infection]]''' |
| − |
| |
| | | | |
| | | | |
| | *'''[[Biophysics of aerosols]]''' | | *'''[[Biophysics of aerosols]]''' |
| | | | |
| − | *'''[[Passive protective equipment]]'''
| |
| | | | |
| − | *'''[[Running your hospital]]'''
| |
| − | {{tp|p=C7198218|t=ä. Practical recommendations for the perioperative management of the patient with suspection or serious infection by coronavirus SARS-CoV? |pdf=|usr=}}
| |
| − | {{tp|p=C7198147|t=ä. Recomendaciones en reanimaci�n cardiopulmonar en pacientes con COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7196403|t=2020. Surgical Management of Patients With COVID-19 Infection Recommendations of the Spanish Association of Surgeons? |pdf=|usr=}}
| |
| − | {{tp|p=C7186769|t=ä. Access Denied: Academic Life Under Lockdown |pdf=|usr=}}
| |
| − | {{tp|p=C7186212|t=ä. Resumption of activity in gastroenterology departments Recommendations by SEPD, AEEH, GETECCU and AEG? |pdf=|usr=}}
| |
| − | {{tp|p=C7160435|t=2020. Neurologie in Zeiten von COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7180676|t=2020. The COVID-19 Pandemic and Implications for Gynaecologic Cancer Care |pdf=|usr=}}
| |
| − | {{tp|p=C7177056|t=ä. Management of neurological care during the COVID-19 pandemic? |pdf=|usr=}}
| |
| − | {{tp|p=C7176377|t=ä. COVID-19 et Chirurgie ORL |pdf=|usr=}}
| |
| − | {{tp|p=C7171436|t=ä. Intelligent technologies help operating mobile cabin hospitals effectively cope with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7168570|t=ä. Coronavirus-Pandemie und ihre Auswirkungen auf Orthop�die und Unfallchirurgie: Operationen, Risiken und Pr�vention?|pdf=|usr=}}
| |
| − | {{tp|p=C7167575|t=ä. ... laryngologie et en phoniatrie ...|pdf=|usr=}}
| |
| − | {{tp|p=C7149297|t=2020. Auswirkungen auf nerven�rztliche, neurologische, psychiatrische Praxen |pdf=|usr=}}
| |
| − | {{tp|p=C7158839|t=ä. Management of the SARS-CoV-2 (COVID-19) coronavirus epidemic in hemodialysis units? |pdf=|usr=}}
| |
| − | {{tp|p=C7158264|t=2020. Personal Protection Prior to Preoperative Assessment?...|pdf=|usr=}}
| |
| − | {{tp|p=C7154214|t=ä. SARS-CoV-2 pandemic and pediatric endoscopic surgery |pdf=|usr=}}
| |
| − | {{tp|p=C7150531|t=ä. SFM India Oriented Guidelines for Ultrasound Establishments During the COVID 19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32412012|t=2020. Perspectives on the death investigation during the COVID-19 pandemic |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | *'''[[Passive protective equipment]]''' |
| | | | |
| | | | |
| | + | |
| | + | *'''[[Running your hospital]]''' |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − |
| |
| | | | |
| | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| − | {{tp|p=C7152912|t=2020. An increasing risk of family violence during the Covid-19 pandemic: Strengthening community collaborations to save lives |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| Zeile 189: |
Zeile 138: |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=C7197568|t=ä. COVID-19 and the Future of Microfinance: Evidence and Insights from Pakistan |pdf=|usr=}}
| |
| − | {{tp|p=C7193138|t=ä. If Everything Has Changed, Why Such a Focus on Bailing Out Capitalism? The Somber Reality Underpinning Covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7191284|t=2020. The COVID-19 pandemic: Considerations for the waste and wastewater services sector |pdf=|usr=}}
| |
| − | {{tp|p=C7183981|t=2020. Startups in times of crisis ? A rapid response to the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=C7183942|t=ä. How the COVID-19 Pandemic May Change the World of Retailing |pdf=|usr=}}
| |
| − | {{tp|p=C7194614|t=2020. Estimating the COVID-19 cash crunch: Global evidence and policy? |pdf=|usr=}}
| |
| − | {{tp|p=C7173828|t=2020. Impact on biometrics of Covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7160643|t=ä. Financial markets under the global pandemic of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7147137|t=2020. Leere Pl�tze: Covid-19 hat die deutsche Wirtschaft fest im Griff Soziale Kontakte werden auf ein Minimum begrenzt, Massenveranstaltungen im gro�en Stile abgesagt, Notfallpl�ne aktiviert Versicherer k�nnten in ihrer Rolle als Stabilit�tsanker mit ihren Produkten gerade jetzt wichtige Signale aussenden, doch sie halten sich zur�ck Fragen von au�en |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 210: |
Zeile 149: |
| | | | |
| | *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
| − | {{tp|p=C7201389|t=ä. Modelling COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=C7197617|t=ä. Six Feet Apart: Lessons Learned from COVID-19 and Social Distancing |pdf=|usr=}}
| + | |
| − | {{tp|p=C7182510|t=2020. Managing disasters amid COVID-19 pandemic: Approaches of response to flood disasters |pdf=|usr=}}
| + | |
| − | {{tp|p=C7158814|t=2020. The intriguing features of COVID?19 in children and its impact on the pandemic? |pdf=|usr=}}
| + | |
| − | {{tp|p=C7158267|t=ä. China?s ongoing battle against the coronavirus: Why did the lockdown strategy work well?|pdf=|usr=}}
| + | |
| − | {{tp|p=C7158265|t=ä. Introduction to Five Years of the Sendai Framework for Disaster Risk Reduction? |pdf=|usr=}}
| + | |
| − | {{tp|p=C7151290|t=2020. Identification of critical airports for controlling global infectious disease outbreaks: Stress-tests focusing in Europe |pdf=|usr=}}
| + | |
| − | {{tp|p=C7149306|t=ä. Mit Immanuel Kant in die zweite Welle der gegenwärtigen Pandemie |pdf=|usr=}} klingt geschwollen aber hardcore: ''Wir sollen so vorgehen, als ob ein Impfstoff gar nicht käme, und jetzt die Zeit umgehend nutzen, die Population dosiert durchseuchen zu lassen und Nebenwirkungen, sprich schwere Verläufe, im Krankenhaussystem aufzufangen und die Betten- und Beatmungskapazität vorzuhalten und zu nutzen. Wir sollten die dosierte Durchseuchung bis November 2020 soweit möglich erlauben, um das „Sommerloch“ der Krankenhausbelastung optimal zu nutzen, den „Geist quasi fraktioniert aus der Flasche lassen“. Um dies umsetzen zu können, müssen noch viel detailliertere Modellierungen, basierend auf Daten aus Deutschland, durchgeführt werden. ''
| + | |
| | | | |
| | | | |
| | | | |
| | *'''[[Remission, recurrence and persistence]]''' | | *'''[[Remission, recurrence and persistence]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | ---- | | ---- |
| | *'''[[Failure of politics and public health guidance]]''' | | *'''[[Failure of politics and public health guidance]]''' |
| − |
| |
| | | | |
| | | | |
| Zeile 241: |
Zeile 175: |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | {{tp|p=C7147143|t=2020. Zwischen Infektionsschutz und Versorgungsauftrag: Eine Zwischenbilanz vier Wochen nach Ausbruch der Pandemie |pdf=|usr=}}
| + | *'''[[misc.]]''' |
| | | | |
| | | | |
| − | *'''[[misc.]]''' | + | *'''[[Research tools]]''' |
| − | {{tp|p=C7195908|t=ä. Editor?s Note: Applied Intelligence and COVID-19 Research |pdf=|usr=}}
| + | |
| − | {{tp|p=C7160436|t=2020. Das Gesundheitssystem muss resilienter werden |pdf=|usr=}}
| + | |
| − | {{tp|p=C7147196|t=2020. Ambulante Versorgung in der Corona-Krise: Gro�teil der COVID-19-Patienten wird in den Praxen behandelt |pdf=|usr=}}
| + | |
| − | {{tp|p=C7149296|t=2020. COVID-19: Risikoabsch�tzung und Planungsgrundlagen f�r unsere Praxen |pdf=|usr=}}
| + | |
| − | {{tp|p=C7160816|t=ä. Aufkl�rung bald nur noch via Skype?!: Zu den M�glichkeiten und Grenzen der Fernaufkl�rung |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Research tools]]''
| + | |
| | + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | | | |
| | *'''[[PrePrint scene]]''' | | *'''[[PrePrint scene]]''' |
| | + | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| | + | |
| | *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| | *'''[[on-topic personal thoughts]]''' | | *'''[[on-topic personal thoughts]]''' |
